出入這8大場所都要戴上口罩  不配合可依法開罰

2020-09-15 09:24:11 健康醫療網

【健康醫療網/編輯部整理】COVID-19疫情延燒全球,我國防疫有成,連續多日無本土病例,指揮中心自6月7日起放寬國內防疫措施,但也發現到近期民眾警戒心下降,整體防疫新生活運動落實情形不盡理想,因此在8月5日提醒民眾,在出入無法保持社交距離、或會密切接觸不特定對象之人潮擁擠或密閉場所時,務必佩戴口罩,也列舉了八大類人潮擁擠或密閉場所,如醫療照護機構、大眾運輸、賣場市集、教育學習場所、展演競賽場所、宗教場所、娛樂場所及大型活動等。

出入8大場所都須戴上口罩  不配合地方政府可依法開罰

中央流行疫情指揮中心強調,國內社區目前相對安全,現階段仍以加強宣導落實防疫新生活運動,同時勸導民眾配合在這八大類場所佩戴口罩為主;惟地方主管機關如已依據傳染病防治法第37條第1項第6款之規定,規劃或已公告八大類場所「強制戴口罩及訂有相關罰則」,指揮中心原則予以尊重,該等縣市則應依傳染病防治法第37條第3項將公告內容函送指揮中心。

感染源不明之本土病例若持續增加 將加強強制措施

此外,指揮中心指出,未來如果國內疫情升溫,有縣市或特定場域出現感染源不明之本土病例時,考量這些場所發生不特定對象或群聚感染的風險較高,需提高對於佩戴口罩之強制力,將要求地方政府及各目的事業主管機關依法公告罰則,並對屢勸不聽者依具體情節裁罰。倘疫情更趨嚴峻,感染源不明之本土病例持續增加,且涉及多數縣市或場域時,將由指揮中心評估並宣布全國性之強制措施,以阻斷傳播鏈。

(文章授權提供/常春月刊)

【延伸閱讀】

求職季到來 打造人見人愛好外型

暑期美麗大翻身! 大學生、社會新鮮人雙眼皮手術詢問度高

疫情下塑身新指標 醫美科技挽救「重」災戶


資料來源:健康醫療網 https://www.healthnews.com.tw/readnews.php?id=47389
喜歡本文請按讚並分享給好友!
健康醫療網https://www.healthnews.com.tw更多健康資訊

閱讀全文
  • 相關廠商

    建誼生技股份有限公司

    Founded and managed by a group of experienced scientists previously working at ScinoPharm Taiwan’s custom synthesis team, KriSan Biotech offers world class services of new drug process and analytical R&D for small molecules and peptides from Pre-clinical (IND) to Phase II. KriSan Biotech was formed to provide high quality chemistry process and analytical R&D services with Asian advantages and western know-how. The company occupies 2,700 m² of suites located in Southern Taiwan Science Park, we are proud to provide the following services: • Process and analytical R&D for small molecules and peptides from Pre-clinical to Phase II • CGMP manufacturing of API for clinical trials (few grams to kilograms scale) • Stability test in accordance to ICH guidelines • CMC Preparation for IND Filing


    建誼生技股份有限公司

    Founded and managed by a group of experienced scientists previously working at ScinoPharm Taiwan’s custom synthesis team, KriSan Biotech offers world class services of new drug process and analytical R&D for small molecules and peptides from Pre-clinical (IND) to Phase II. KriSan Biotech was formed to provide high quality chemistry process and analytical R&D services with Asian advantages and western know-how. The company occupies 2,700 m² of suites located in Southern Taiwan Science Park, we are proud to provide the following services: • Process and analytical R&D for small molecules and peptides from Pre-clinical to Phase II • CGMP manufacturing of API for clinical trials (few grams to kilograms scale) • Stability test in accordance to ICH guidelines • CMC Preparation for IND Filing